FindTrial
Sign In

Prospective multicenter observational cohort to assess quality of life, cost-effectivity and functional outcomes following minimal invasive surgical techniques for rectal cancer in ‘dedicated centers’

Prospective multicenter observational cohort to assess quality of life, cost-effectivity and functional outcomes following minimal invasive surgical techniques for rectal cancer in ‘dedicated centers’

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON20512
Enrollment
1200
Registered
2021-09-15
Start date
2021-10-04
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal carcinoma

Interventions

Not applicable.

Sponsors

University Medical Center Groningen.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients receiving L-TME, R-TME and TaTME between October 2021 and October 2023 in participating centers will be assessed for eligibility for inclusion. Included will be patients aged = 18 years, registered in the DCRA database, diagnosed with rectal cancer defined as the lower border of the tumor under the sigmoidal take off, undergoing elective and curative treatment in a dedicated center.

Exclusion criteria

Exclusion criteria: There are no predefined exclusion criteria.

Design outcomes

Primary

MeasureTime frame
The primary objective of this study is to compare QoL at 1 year postoperatively between L-TME, R-TME, and TaTME.—

Secondary

MeasureTime frame
Secondary objectives are to compare CE, functional outcomes, short term outcomes, and long term oncological outcomes of L-TME, R-TME and TaTME.—

Contacts

Public ContactRitch Geitenbeek

University Medical Center Groningen

rtj.geitenbeek@meandermc.nl0031616936929

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)